US4583981A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Parenteral controlled therapy, using a porous matrix with parenteral agent
Assignee: Alza Corp
•
Filing: 1985-01-07
•
Granted: 1986-04-22
•
Expires: 2005-01-07
Abstract
Abstract A parenteral delivery set is disclosed for administering a beneficial agent to a recipient. The set comprises (a) a primary container of a medical fluid; (b) a primary tubing in fluid communication with the primary container; (c) a secondary container of a medical fluid; (d) a secondary tubing in fluid communication with the secondary container; (e) a formulation chamber connected to the secondary tubing and housing an agent dispensing device or the beneficial agent; and (f) a common tubing in communication with the primary tubing and the secondary tubing for communicating the set to the recipient.
Inventors
- 👤 John Urquhart
- 👤 Felix Theeuwes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 05:26
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/1407; A61M5/142; A61M5/145; A61M2005/14513
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
151 words
A parenteral delivery set for administering a beneficial agent formulation to a warm-blooded animal, the delivery set comprising: (a) a primary tube for the flow of a parenterally acceptable fluid therethrough; (b) a secondary tube for the flow of a parenterally acceptable fluid therethrough; (c) a formulation chamber in communication with the secondary tube, the formulation chamber comprising: (1) a wall that surrounds an internal space; (2) an inlet for letting fluid enter the formulation chamber; (3) a beneficial agent delivery device in the formulation chamber, the delivery device comprising a matrix formed of a microporous material, and a beneficial agent distributed in the microporous material; (4) an outlet for letting an agent formulation exit the formulation chamber; and, (d) a common tube in communication with the primary tube for receiving fluid from the primary tube, and in communication with the secondary tube for receiving agent formulation from the secondary tube.
Claim 2
Dependent Claim
151 words
A parenteral delivery set for administering a beneficial agent formulation to a warm-blooded animal, the delivery set comprising: (a) a primary tube for the flow of a parenterally acceptable fluid therethrough; (b) a secondary tube for the flow of a parenterally acceptable fluid therethrough; (c) a formulation chamber in communication with the secondary tube, the formulation chamber comprising: (1) a wall that surrounds an internal space; (2) an inlet for letting fluid enter the formulation chamber; (3) a beneficial agent delivery device in the formulation chamber, the delivery device comprising a matrix formed of a microporous material, and a beneficial agent distributed in the microporous material; (4) an outlet for letting an agent formulation exit the formulation chamber; and, (d) a common tube in communication with the primary tube for receiving fluid from the primary tube, and in communication with the secondary tube for receiving agent formulation from the secondary tube.
Claim 3
Dependent Claim
25 words
The parenteral delivery set for administering the beneficial agent formulation according to claim 1, wherein a drip chamber is in communication with the formulation chamber.
Claim 4
Dependent Claim
25 words
The parenteral delivery set for administering the beneficial agent formulation according to claim 1, wherein a drip chamber is in communication with the secondary tube.
References Cited (Backward Citations)
US2954028A
Cited
US3001525A
Cited
GB982107A
Cited
US3305446A
Cited
CH497181A
Cited
US3322114A
Cited
US4061141A
Cited
US3993073A
Cited
US3854480A
Cited
US3797494A
Cited
US3995631A
Cited
US3797485A
Cited
US3756237A
Cited
US3760984A
Cited
US3948254A
Cited
US3756390A
Cited
US3845770A
Cited
US3921636A
Cited
US4177256A
Cited
US3848603A
Cited
US3921635A
Cited
US3941126A
Cited
US3993072A
Cited
US3976068A
Cited
US4203439A
Cited
US4323457A
Cited
US4217894A
Cited
US4233973A
Cited
US4256104A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-04-21 | 1989-10-21 | 1990-04-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-04-21 | 1993-10-21 | 1994-04-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-04-21 | 1997-10-21 | 1998-04-22 | $7700.00 | Window Closed / Lapsed |